A study to evaluate ASP0367 in participants with reduced maximum oxygen uptake due to poor systemic oxygen extraction

Trial Identifier:	0367-CL-1101
Sponsor:	Astellas Pharma Global Development, Inc.
Start Date:	June 2021
Primary Completion Date:	December 2022
Study Completion Date:	December 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
USA, MA	Boston, MA, USA, 02115

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.